Karussis DM - Search Results

1

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation.

Karussis DM, Slavin S, Ben-Nun A, Ovadia H, Vourka-Karussis U, Lehmann D, Mizrachi-Kol R, Abramsky O. Karussis DM, et al. J Neuroimmunol. 1992 Aug;39(3):201-10. doi: 10.1016/0165-5728(92)90254-i. J Neuroimmunol. 1992. PMID: 1644896

2

Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.

Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A. Karussis DM, et al. J Immunol. 1992 Mar 15;148(6):1693-8. J Immunol. 1992. PMID: 1541813

3

Inoculation of BCL1 lymphoma cells into CSJL/J F1 mice inhibits acute experimental autoimmune encephalomyelitis.

Abramsky O, Karussis DM, Mizrachi-Koll R, Lehmann D. Abramsky O, et al. Among authors: karussis dm. Isr J Med Sci. 1994 Jan;30(1):1-6. Isr J Med Sci. 1994. PMID: 7511133

4

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

Karussis DM, Vourka-Karussis U, Lehmann D, Ovadia H, Mizrachi-Koll R, Ben-Nun A, Abramsky O, Slavin S. Karussis DM, et al. J Clin Invest. 1993 Aug;92(2):765-72. doi: 10.1172/JCI116648. J Clin Invest. 1993. PMID: 7688762 Free PMC article.

5

Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).

Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S. Karussis DM, et al. Clin Exp Immunol. 1995 Apr;100(1):111-7. doi: 10.1111/j.1365-2249.1995.tb03611.x. Clin Exp Immunol. 1995. PMID: 7697909 Free PMC article.

6

Immunomodulation of experimental autoimmune myasthenia gravis with linomide.

Karussis DM, Lehmann D, Brenner T, Wirguin I, Mizrachi-Koll R, Sicsic C, Abramsky O. Karussis DM, et al. J Neuroimmunol. 1994 Dec;55(2):187-93. doi: 10.1016/0165-5728(94)90009-4. J Neuroimmunol. 1994. PMID: 7829669

7

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.

Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Ben-Nun A, Kalland T, Abramsky O. Karussis DM, et al. Ann Neurol. 1993 Nov;34(5):654-60. doi: 10.1002/ana.410340506. Ann Neurol. 1993. PMID: 8239559

8

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Kalland T, Abramsky O. Karussis DM, et al. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6400-4. doi: 10.1073/pnas.90.14.6400. Proc Natl Acad Sci U S A. 1993. PMID: 8341645 Free PMC article.

9

Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.

Lehmann D, Karussis DM, Fluresco D, Mizrachi-Koll R, Ovadia H, Shezen E, Kalland T, Abramsky O. Lehmann D, et al. Among authors: karussis dm. J Neuroimmunol. 1997 Apr;74(1-2):102-10. doi: 10.1016/s0165-5728(96)00211-1. J Neuroimmunol. 1997. PMID: 9119961

10

Oral administration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis.

Lehmann D, Karussis D, Misrachi-Koll R, Shezen E, Ovadia H, Abramsky O. Lehmann D, et al. J Neuroimmunol. 1994 Feb;50(1):35-42. doi: 10.1016/0165-5728(94)90212-7. J Neuroimmunol. 1994. PMID: 8300856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters